Novel Genetic Variants Associated with Diabetic Neuropathy Risk in Type 2 Diabetes: A Whole-Exome Sequencing Approach

Area of Science:

• Genetics
• Neurology
• Endocrinology

Background:

• Diabetic neuropathy pathogenesis involves metabolic and genetic factors.
• Type 2 diabetes is a leading cause of neuropathy.
• Identifying genetic risk factors is crucial for understanding disease mechanisms.

Purpose of the Study:

• To identify novel genetic variants associated with diabetic neuropathy risk.
• To reanalyze whole-exome sequencing data for new genetic associations.
• To explore the functional implications of identified genetic variants.

Main Methods:

• Whole-exome sequencing data reanalysis.
• Statistical analysis to identify single nucleotide polymorphisms (SNPs) with significant associations.
• Bioinformatic analysis to determine the potential function of identified variants.

Main Results:

• Seven novel SNPs associated with diabetic neuropathy risk were identified.
• Significant associations were found with intronic variants in TTN, PLCB1, CCNI, and CDC34.
• A 5'-upstream variant in BTG2 was also identified.
• Identified variants are implicated in muscle elasticity, neurotransmission, endothelial regeneration, and apoptosis resistance.

Conclusions:

• Genetic factors play a multifaceted role in the development of diabetic neuropathy.
• The identified variants provide new insights into the pathogenesis of the condition.
• These findings may contribute to improved risk stratification and the development of novel therapies for diabetic neuropathy.